Attention Deficit Disorder With Hyperactivity Clinical Trial
— MyBOfficial title:
Clinical Evaluation of a Brain Computer Interfaces (BCI)-Based Training of Attention in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Verified date | October 2019 |
Source | Hospices Civils de Lyon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This project aims to assess the evolution of symptoms in ADHD children from 8 to 17 years,
with various types of attention training.
Different groups A, B and C will be evaluated: the first with Neurofeedback training, the
second with a similar training but not indexed on brain activity and the third without
training.
30 patients will be randomly assigned to groups A and B according to a ratio 2:1.
Others patients who meet the same criteria but for logistical reasons cannot comply with the
training constraints will be assigned to group C.
Children included in groups A and B will participate in training sessions (Neurofeedback and
control training, respectively) as well as in four evaluation sessions. Children in group C
will only participate in evaluation sessions (baseline control group).
Patients of groups A and B will be followed over 6 months: 4 months of training and a
follow-up evaluation 2 months after training.
Patients of group C will be followed each 2 months for 6 months. This study uses
electro-encephalography measures, serious video game, neuropsychological tests and
questionnaires.
It also uses actigraphy measures to evaluate sleep quality.
Status | Completed |
Enrollment | 52 |
Est. completion date | September 9, 2019 |
Est. primary completion date | September 9, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 8 Years to 17 Years |
Eligibility |
Inclusion Criteria: - Children and teenagers aged from 8 to 17 years' old - Children and teenagers with a deficit attention disorder with or without hyperactivity, in the mixed form or in a pure inattentive form according to Diagnostique et Statistique des troubles Mentaux (DSM)-V. - Children and teenagers having a score in Verbal Comprehension Index (or Index Verbal Reasoning) and Perceptual Reasoning Index (or Index Reasoning fluid) = 80 of WISC IV or V test, not older than two years. - Children and teenagers without psychostimulant treatment - Children and teenagers with psychostimulant treatment agreed to achieve a therapeutic break at each visit day and with a stable dose during all the study. - Children and teenagers whose parents have agreed and signed informed consent form of the study. Exclusion Criteria: - Children aged less than 8 and teenagers are more than 18 years' old. - Children and teenagers having a score in Verbal Comprehension Index (or Index Verbal Reasoning) and Perceptual Reasoning Index (or Index Reasoning fluid) < 80 of WISC IV or V test, not older than two years. - Children and teenagers with developmental disorder except "Dys" disorders. - Children and teenagers with pure hyperactivity (without attentional deficit) - Children and teenagers with epilepsy except benign epilepsies (without brain damage), free of crisis for two years and without treatment. - Children and teenagers with ADHD with conduct disorders and aggression - Children and teenagers with ADHD and Tourette's syndrome. - Patients treated by anti / epilepsy or psychotropic treatments (with the exception of psychostimulant treatment). - Patients with psychostimulant treatment and whose parents aren't agreed to achieve a therapeutic break at each visit day. - Patients with visual deficiency uncorrectable with lenses or glasses. |
Country | Name | City | State |
---|---|---|---|
France | Hospices Civils de Lyon | Bron |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Evaluation of the relative effect on symptoms of inattention between the two proposed training techniques, A and B, with the ADHD Rating Scale in children with ADHD | Questions with odd numbers interested in the dimension "inattentive" will particularly be studied. The investigator expect an improvement in the type of score: ''ADHD-Inattentive'' children in group A compared to children in Group B. More specifically, he expect to improve responses to questions number 1,3,5,7,9,11,13,15 and 17. By definition, an evolving response would be to move from " 2=Often; 3=Very often" to " 1=Sometimes; 0=Rarely/Never". | every two months over six months. | |
Secondary | Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children | ADHD Rating Scale (questions with odd numbers) will be performed ADHD children from groups A, B and C will be compared | every months over six months. | |
Secondary | Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children | Bron/Lyon Attention Stability test (BLAST) test will be performed ADHD children from groups A, B and C will be compared | every months over six months. | |
Secondary | Neuropsychological assessments of effects of training on the symptoms of inattention in ADHD children | Wechsler Intelligence Scale for Children (WISC) subtests will be performed ADHD children from groups A, B and C will be compared | every months over six months. | |
Secondary | Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children | Wechsler Intelligence Scale for Children (WISC) will be performed ADHD children from groups A, B and C will be compared | every months over six months. | |
Secondary | Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children | ADHD Rating Scale (questions with odd numbers) will be performed ADHD children from groups A, B and C will be compared | every months over six months. | |
Secondary | Neuropsychological assessments of the effects of the lack of training on the symptoms of inattention in ADHD children | Bron/Lyon Attention Stability test (BLAST) will be performed ADHD children from groups A, B and C will be compared | every months over six months. | |
Secondary | Compare the effects of the two types of trainings on the hyperactivity symptoms in ADHD children using neuropsychological assessments. | ADHD Rating Scale (questions with even numbers), Test d'évaluation de l'Attention (TAP) and Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children | ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children | Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | neuropsychological assessments of the effects of the two types of trainings on the hyperactivity symptoms in ADHD children | Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children | Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children | Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | neuropsychological assessments of the effects of the lack of training on the impulsivity symptoms in ADHD children | ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children | Continuous Performance Test (CPT) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children | ADHD Rating Scale (questions with even numbers) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | neuropsychological assessments of the effects of the lack of training on the hyperactivity symptoms in ADHD children | Test d'évaluation de l'Attention (TAP) will be performed ADHD children from groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | TAP will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | CPT will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | BLAST will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups A (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | ADHD Rating Scale (questions with odd numbers)will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | TAP will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | CPT will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | BLAST will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups B (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | TAP will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | CPT will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | BLAST will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify whether the changes in inattentive symptoms in groups C (Neurofeedback training) correlate with changes in specific EEG parameter, namely the P300 wave. | Attention and Distractibility Questionnaire (for children) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP)) | ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP)) | TAP will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP)) | BLAST will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Slow Cortical Potential (SCP)) | Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | TAP will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | BLAST will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the classical Neurofeedback biomarkers correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR) | ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR) | TAP will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR) | BLAST will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Theta/Beta Ratio (TBR) | Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | TAP will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | BLAST will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the classical Neurofeedback biomarkers TBR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR) | ADHD Rating Scale (questions with odd numbers) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR) | TAP will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR) | BLAST will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Quantify the evolution of the classical Neurofeedback biomarkers Sensori-Moteur Rythm (SMR) | Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | ADHD Rating Scale (questions with odd numbers)will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | TAP will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | BLAST will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Assess whether the Neurofeedback biomarkers SMR correlate with the evolution of behavioral and primary neurophysiological measures (P300) in all groups. | Attention and Distractibility Questionnaire (child) will be evaluated ADHD children of groups A, B and C will be compared | every two months over six months | |
Secondary | Evaluate the impact of the trainings on the sleep quality in ADHD children. | Sleep questionnaires will be distributed ADHD children in groups A, B and C will be compared. | every two months over six months. | |
Secondary | Evaluate the impact of the trainings on the sleep quality in ADHD children. | The sleep data may also be collected using an actigraph (ancillary study). ADHD children in groups A, B and C will be compared. | every two months over six months. | |
Secondary | Evaluating the impact of the trainings on the quality of life in ADHD children. | The Child Behavior CheckList (CBCL) questionnaire will be performed Groups A, B and C will be compared. |
every two months over six months | |
Secondary | Evaluating the impact of the trainings on the quality of life in ADHD children. | Information about the quality of life will be also collected in a logbook by family members and provided at each visit. Groups A, B and C will be compared. |
every two months over six months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00202605 -
Safety and Efficacy of SPD465 in Adults With ADHD
|
Phase 2 | |
Not yet recruiting |
NCT02677519 -
A 12-Month Open Label Safety Study of Aptensio XR® in Children Ages 4-5 Years Diagnosed With ADHD
|
Phase 4 | |
Completed |
NCT02730572 -
Concerta (Methylphenidate) -To-Generic Switch Study
|
N/A | |
Completed |
NCT01681082 -
Psychological Effects of Tai Chi Training
|
N/A | |
Active, not recruiting |
NCT01330693 -
Cortical Excitability: Phenotype and Biomarker in Attention-deficit, Hyperactivity Disorder (ADHD) Therapy
|
Phase 3 | |
Completed |
NCT00830700 -
Children's Attention Deficit Disorder With Hyperactivity (ADHD) Telemental Health Treatment Study
|
N/A | |
Completed |
NCT01012622 -
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
|
Phase 4 | |
Completed |
NCT00626236 -
Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems
|
Phase 2 | |
Completed |
NCT00598182 -
Adherence and Long-term Effect of OROS Methylphenidate (CONCERTA): A Follow-up Study
|
N/A | |
Completed |
NCT00381407 -
Organizational Skills Training for Children With Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00178503 -
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children
|
Phase 2/Phase 3 | |
Completed |
NCT00247572 -
Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
|
Phase 2 | |
Completed |
NCT00557011 -
NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
|
Phase 2 | |
Completed |
NCT00218322 -
Effectiveness of ATMX in Treating Adolescents With ADHD and SUD
|
Phase 4 | |
Completed |
NCT00118911 -
Cognitive Behavioral Therapy for Treatment of Adult Attention Deficit Hyperactivity Disorder
|
N/A | |
Completed |
NCT00071656 -
Psychosocial Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Type I
|
N/A | |
Active, not recruiting |
NCT00057668 -
Preventing Behavior Problems in Children With ADHD
|
Phase 2 | |
Completed |
NCT00050050 -
Cognitive Behavioral Therapy for Adult Attention Deficit Hyperactivity Disorder
|
Phase 1 | |
Completed |
NCT00050622 -
Behavioral Treatment, Drug Treatment, and Combined Treatment for Attention Deficit Hyperactivity Disorder (ADHD)
|
N/A | |
Completed |
NCT00031395 -
Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children
|
Phase 3 |